GeneDx Holdings (WGSWW) Gains from Investment Securities (2020 - 2026)
GeneDx Holdings (WGSWW) reported Gains from Investment Securities of $495000.0 for Q1 2026, up 277.86% quarter-over-quarter from $131000.0 in Q4 2025.
GeneDx Holdings (WGSWW) Gains from Investment Securities (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGSWW) has 7 years of Gains from Investment Securities data on file, last reported at $495000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $495000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (up 31.64% YoY), and the FY2025 annual result was $2.5 million, down 9.22% from the prior year.
- Gains from Investment Securities improved to $495000.0 in Q1 2026 per WGSWW's latest filing, from $131000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $57.6 million in Q4 2022 and troughed at -$56.0 million in Q3 2022.
- A 5-year average of $485500.0 and a median of $511500.0 in 2024 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities soared 1041.6% in 2024, then tumbled 304.73% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $57.6 million in 2022, then sank by 105.73% to -$3.3 million in 2023, then plunged by 163.09% to -$8.7 million in 2024, then jumped by 101.51% to $131000.0 in 2025, then soared by 277.86% to $495000.0 in 2026.
- Business Quant data shows WGSWW's Gains from Investment Securities at $495000.0 in Q1 2026, $131000.0 in Q4 2025, and $3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | GeneDx Holdings | - | - | 68.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 495,000.00 |
| Mar 31, 2026 | 495,000.00 |
| Dec 31, 2025 | 131,000.00 |
| Dec 31, 2025 | 131,000.00 |
| Sep 30, 2025 | 3.40 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | -1.08 Mn |
| Jun 30, 2025 | -1.08 Mn |
| Dec 31, 2024 | -8.69 Mn |
| Dec 31, 2024 | -8.69 Mn |
| Sep 30, 2024 | 10.40 Mn |
| Sep 30, 2024 | 10.40 Mn |
| Jun 30, 2024 | 528,000.00 |
| Jun 30, 2024 | 528,000.00 |
| Mar 31, 2024 | 462,000.00 |
| Mar 31, 2024 | 462,000.00 |
| Dec 31, 2023 | -3.30 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Sep 30, 2023 | 911,000.00 |
| Sep 30, 2023 | 911,000.00 |